POSTERS ESMO 2024

esmo

Cáncer de pulmón

No microcítico localmente avanzado

Judit Sanz Beltran

acceso

Impact of systemic treatment on cardiac events following chemoradiotherapy in stage III lung cancer patients

Judit Sanz Beltran

Hospital de la Santa Creu i Sant Pau. Barcelona

Cáncer de pulmón

No microcítico metastásico

Beatriz Jiménez Munarriz

acceso

Predictive value of weight and BSA in assessing toxicity during ALK-TKIs in non-small cell lung cancer

Beatriz Jiménez Munarriz

Princess Margaret Cancer Centre. Toronto, Canadá

Lisardo Ugidos De la Varga

acceso

Osimertinib versus first/second generation tyrosine kinase inhibitors as first line therapy for metastatic EGFR-mutated non-small cell lung carcinoma: overall survival using real world data from TrinetX platform

Lisardo Ugidos De la Varga

Hospital Universitario Vithas Madrid

Una iniciativa científica de:

Con el patrocinio de:

REGENERON